Biotech ETF Channel

The segment is delivering some impressive gains after a bout of investor doubt.

U.S.-listed ETFs took in $3.6 billion in new money in the latest week.

Inflows into U.S.-listed ETFs were positive, but they fell significantly from the lofty levels of the past few weeks. 

Issuers take different approaches to industry and sector exposure.

ALPS isn’t just an ETF issuer—it’s got footprints throughout the industry.

Telecommunications lagged in February, while health care shined as the top-performing sector.

Health care ETFs have largely shrugged off the Republican health care bill.

Also, Morningstar to offer mutual funds for exclusive use of advisors.